EUVIMEDEUVIMED entdecken
Crossref

Inflammatory Indices in First Trimester as Predictors of Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes

Yu Sun, Cuihua Shen, Jia Li, Wei Kang, Xin Li, Wei Fan iD

American Journal of Reproductive Immunology · 2025

DOI: 10.1111/aji.70070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Yu Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Kunming City Maternal and Child Health Hospital, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Diabetes, Gestational, Inflammation, Pregnancy Trimester, First. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To explore the association between systemic inflammatory markers (systemic inflammation response index [SIRI], systemic immune inflammation index [SII], interleukin [IL]‐33, and soluble tumorigenicity 2 [sST2]) and gestational diabetes mellitus (GDM), as well as adverse pregnancy outcomes (APOs), and to assess the impact of glycemic control on these relationships.

Methods

A total of 777 participants were included, comprising 476 women with GDM and 301 without. Clinical characteristics, inflammatory markers, and pregnancy outcomes were analyzed. Logistic regression was employed to assess the risk of GDM and APOs associated with elevated inflammatory indices and glycemic control. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curves.

Results

Women with GDM exhibited significantly higher levels of SII, SIRI, IL‐33, and sST2. Multivariate logistic regression demonstrated that SII, SIRI, IL‐33, and sST2 were independent predictors of GDM. Moreover, the highest tertiles of SII, SIRI, and IL‐33 were strongly associated with APO risk. ROC analysis revealed that SII had the highest predictive value for GDM (AUC 0.763), while IL‐33 had the greatest predictive accuracy for APOs (AUC 0.669). Effective glycemic control was associated with reduced inflammatory marker levels (SII, aOR 3.9; SIRI, aOR 3.7; IL‐33, aOR 2.4) and a decreased risk of APOs and large‐for‐gestational‐age (LGA) infants in women with GDM.

Conclusions

Elevated SII, SIRI, IL‐33, and sST2 are significant predictors of GDM and APOs, with SII being the most robust predictor of GDM and IL‐33 for APOs. Glycemic control reduces inflammation and may improve pregnancy outcomes in women with GDM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalInflammationPregnancy Trimester, FirstHumansFemalePregnancyAdultPregnancy OutcomeBiomarkersInterleukin-33Interleukin-1 Receptor-Like 1 Protein

Stichwörter der Autor:innen

adverse pregnancy outcomesgestational diabetes mellitusinterleukin‐33soluble tumorigenicity 2system inflammation response indexsystemic immune inflammation index

Substanzen

BiomarkersInterleukin-33Interleukin-1 Receptor-Like 1 Protein

Autor:innen und Institutionen

  • Department of Obstetrics, Kunming City Maternal and Child Health Hospital, Kunming, Yunnan, China.

ORCID-Profile: Wei Fan

Zitieren

APA

Sun, Y., Shen, C., Li, J., Kang, W., Li, X., & Fan, W. (2025). Inflammatory Indices in First Trimester as Predictors of Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70070

Vancouver

Sun Y, Shen C, Li J, Kang W, Li X, Fan W. Inflammatory Indices in First Trimester as Predictors of Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70070

BibTeX
@article{Sun2025,
  author = {Sun, Yu and Shen, Cuihua and Li, Jia and Kang, Wei and Li, Xin and Fan, Wei},
  title = {Inflammatory Indices in First Trimester as Predictors of Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes},
  journal = {American Journal of Reproductive Immunology},
  year = {2025},
  doi = {10.1111/aji.70070}
}
Kostenlos starten →